| 1 |
35210989 | Imaging of Reactive Astrogliosis by Positron Emission Tomography. | 2022 |
1 |
| 2 |
33990649 | Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer's disease. | 2021 May 14 |
2 |
| 3 |
34656177 | Characterization of an APP/tau rat model of Alzheimer's disease by positron emission tomography and immunofluorescent labeling. | 2021 Oct 16 |
1 |
| 4 |
33222700 | Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue. | 2020 Nov 23 |
1 |
| 5 |
29113604 | Tau accumulation in two patients with frontotemporal lobe degeneration showing different types of aphasia using 18F-THK-5351 positron emission tomography: a case report. | 2018 May |
3 |
| 6 |
29716656 | Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias. | 2018 May 1 |
2 |
| 7 |
27797445 | Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy. | 2017 Jan |
5 |
| 8 |
27856627 | In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317. | 2017 Jun |
5 |
| 9 |
27355840 | Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. | 2016 |
1 |
| 10 |
26461913 | Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F]THK-5117 Positron Emission Tomography. | 2015 |
1 |
| 11 |
23100049 | Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology. | 2013 Jan |
4 |